Site-specific gene targeting for gene expression in eukaryotes.
Major advances in the use of site-specific recombinases to facilitate sustained gene expression via chromosomal targeting have been made during the past year. New tools for genomic manipulations using this technology include the discovery of epitopes in recombinases that confer nuclear localization, crystal structures that show the precise topology of recombinase-DNA-substrate synaptic complexes, manipulations of the DNA recognition sequences that select for integration over excision of DNA, and manipulations that make changes in gene expression inducible by drug administration. In addition, endogenous eukaryotic and mammalian DNA sequences have been discovered that can support site-specific recombinase-mediated manipulations.
Gorman
C
C
DNA Bridges, Inc., San Francisco, CA 94117, USA. cori@dnabridges.com
Bullock
C
C
D000818:Animals; D030801:Animals, Genetically Modified; D004254:DNA Nucleotidyltransferases / Q000378:metabolism*; D005057:Eukaryotic Cells; D015870:Gene Expression; D018390:Gene Targeting / Q000379:methods*; D015316:Genetic Therapy / Q000379:methods; D019426:Integrases / Q000378:metabolism; D011995:Recombination, Genetic; D013379:Substrate Specificity; D014764:Viral Proteins
D014764:Viral Proteins; C045073:Cre recombinase; D004254:DNA Nucleotidyltransferases; D019426:Integrases